Why Pharma Industry Should Target Middle East & Africa Market?

August 2, 2019 |
0
87

The global pharmaceutical market was worth $934.8 billion in 2017 and will reach $1,170 billion in 2021, growing at 5.8%. The Middle East and North Africa is the region that is earmarked for quick expansion of the pharmaceutical sector. According to research, the Pharmaceutical market has reached $25B in value in 2018, with a short-term growth of 13% from 2017 to 2018. This robust market is forecasted to grow to $60B by 2025.

The growth in the pharmaceutical sector in our region is mainly attributed to changing population dynamics, where the population is changing, but also ageing. The boom in the economy from oil production and tourism has led to an affluent and sedentary lifestyle which is the main source of increase in various non-contagious chronic illnesses. Easy and affordable access to healthcare systems has contributed to more purchases of medication and other general health & hygiene consumables. The Over the Counter (OTC) segment is a fast-growing segment, with the MENA region being the second fastest growing region in the world.

Currently 62% of the MEA market share is held by multinationals; however, the local and regional companies are quickly gaining pace. Major economic initiatives have been launched by the governments of the Middle East & Africa to become self-reliant in providing healthcare. This has led to a major growth of production units from the drug manufacturers. Moreover, as a large number of patents on medication expire, the local/regional drug manufacturers have an opportunity to produce generic alternatives.

Thus, the need of the market and initiatives from the government make our region a lucrative and profitable region for the pharmaceutical industry to tap in.

DUPHAT is committed to providing complete solutions to the pharmaceutical industry, by representing the entire Pharma value chain in one place with its two distinct segments:

• DUPHAT TECH which brings together upstream and midstream pharmaceutical manufacturers from R&D, processing & packaging machineries, ingredients/ APIs, quality control to medical coding, labeling, storage & logistics.
• DUPHAT showcases downstream activities from finished formulations – both patented& generics, OTCs and related medical devices sold through pharmacies.

After 24 editions, DUPHAT has become the most sought-after event for key decision markers in the Pharmaceutical industry in the Middle East & Africa as it features the latest trends from automation of pharmacies, robotics and upgraded pharmacy services to finished formulations. DUPHAT also annually attracts the top 100 global pharmaceutical companies and regional manufacturers to exhibit their latest products and services in this field.

Enhance your brand and increase your visibility!

  • Get access to the world’s fastest growing pharma market & develop your
    market share in the region
  • Engage & influence pharmacists who sell your OTC products (Skincare,
    Hygiene, Supplements, etc.)
  • Build new business relationships within the industry by meeting C-Level delegates
  • Pre-book your appointments with the industry decision makers
  • Understand the latest government regulations and policies and the
    upcoming trends

The scientific committee of DUPHAT brings forth the latest & future innovations and sciences to keep the audience up-to-date with the industry developments. Intensive 3-day conferences, workshops and poster presentations are channels to get engaged in the educational platform.

When the Exclusive Regulatory & Manufacturers Conference, was held for the first time with a focus on the Regional Pharma Industry & led by experts, it aimed to support manufacturers in the evolving pharma industry. Now, it is the go-to event for delegates and participants to stay up-to-date with the latest trends and developments in this field. The event presents 3 days of learning to enhance the skills and knowledge, with dedicated parallel conference tracks that focus on:

  • Regulatory
  • Manufacturing
  • Pharmacovigilance & Pharmacoepidemiology
  • Career Development
  • Challenges in Practice
  • Updates in Pharmaceutical Sciences